Circulating Retinol-Binding Protein-4, Insulin Sensitivity, Insulin Secretion, and Insulin Disposition Index in Obese and Nonobese Subjects
Author:
Broch Montserrat12, Vendrell Joan1, Ricart Wifredo34, Richart Cristóbal12, Fernández-Real José-Manuel34
Affiliation:
1. Reseach Unit, Pere Virgili Institute for Biomedical Research, Tarragona, Spain 2. CIBER Fisiopatología Obesidad y Nutrición CB06/03/0011, Instituto de Salud Carlos III, Hospital Joan XXII, Tarrogona, Spain 3. Diabetes, Endocrinology and Nutrition Unit, Dr. Josep Trueta Hospital, Girona, Spain 4. Girona Institute for Biomedical Research and CIBER Fisiopatología Obesidad y Nutrición CB06/03/0010, Instituto de Salud Carlos III, Girona, Spain
Abstract
OBJECTIVE—Recent investigations disclosed an upregulation of retinol-binding protein-4 (RBP4) in the adipose tissue of several insulin-resistant mouse models and increased serum RBP4 concentration in subjects with obesity and type 2 diabetes in association with insulin resistance. There is some experimental evidence that RBP4 also could been linked to insulin secretion.
RESEARCH DESIGN AND METHODS—We aimed to evaluate insulin secretion, insulin sensitivity, insulin disposition index (minimal model analysis), and circulating RBP4 (enzyme-linked immunosorbent assay) in nondiabetic men with a wide range of obesity (n = 107).
RESULTS—Serum RBP4 concentration was nonsignificantly different among lean, overweight, and obese subjects. Circulating RBP4 was not associated with age, BMI, waist-to-hip ratio, or metabolic parameters, including insulin sensitivity (r = −0.03, P = 0.6). On the contrary, circulating RBP4 was negatively associated with insulin secretion, especially in obese subjects (r = −0.48, P = 0.007), in whom RBP4 also was linked to insulin disposition index (r = −0.44, P = 0.01). On multiple regression analyses to predict insulin secretion (acute insulin response [AIRg]), insulin sensitivity was the only factor that contributed to 17% of AIRg variance in nonobese subjects. In obese subjects, however, RBP4 emerged as an independent factor that contributed independently to AIRg variance (23%).
CONCLUSIONS—Our results suggest that oversecretion of RBP4 may negatively affect β-cell function directly or by preventing the binding of transthyretin to its receptor. These mechanisms could be behind the association between increased circulating RBP4 and type 2 diabetes. RBP4 could be one signal from insulin-resistant tissues that impacts on β-cell secretion.
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference14 articles.
1. Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB: Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354: 2552–2563, 2006 2. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB: Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356–362, 2005 3. Zovich DC, Orologa A, Okuno M, Kong LW, Talmage DA, Piantedosi R, Goodman DS, Blaner WS: Differentiation-dependent expression of retinoid-binding proteins in BFC-1 beta adipocytes. J Biol Chem 267:13884–13889, 1992 4. Tsutsumi C, Okuno M, Tannous L, Piantedosi R, Allan M, Goodman DS, Blaner WS: Retinoids and retinoid-binding protein expression in rat adipocytes. J Biol Chem 267:1805–1810, 1992 5. Janke J, Engeli S, Boschmann M, Adams F, Böhnke J, Luft FC, Sharma AM, Jordan J: Retinol-binding protein 4 in human obesity. Diabetes 55:2805–2810, 2006
Cited by
124 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|